• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MYCN 癌基因与神经母细胞瘤分化。

The MYCN oncogene and differentiation in neuroblastoma.

机构信息

Department of Microbiology Tumor and Cell Biology, Karolinska Institutet, SE-171 77 Stockholm, Sweden.

出版信息

Semin Cancer Biol. 2011 Oct;21(4):256-66. doi: 10.1016/j.semcancer.2011.08.001. Epub 2011 Aug 9.

DOI:10.1016/j.semcancer.2011.08.001
PMID:21849159
Abstract

Childhood neuroblastoma exhibits a heterogeneous clinical behavior ranging from low-risk tumors with the ability to spontaneously differentiate and regress, to high-risk tumors causing the highest number of cancer related deaths in infants. Amplification of the MYCN oncogene is one of the few prediction markers for adverse outcome. This gene encodes the MYCN transcriptional regulator predominantly expressed in the developing peripheral neural crest. MYCN is vital for proliferation, migration and stem cell homeostasis while decreased levels are associated with terminal neuronal differentiation. Interestingly, high-risk tumors without MYCN amplification frequently display increased c-MYC expression and/or activation of MYC signaling pathways. On the other hand, downregulation of MYCN leads to decreased proliferation and differentiation, emphasizing the importance of MYC signaling in neuroblastoma biology. Furthermore, expression of the neurotrophin receptor TrkA is associated with good prognosis, the ability to differentiate and spontaneous regression while expression of the related TrkB receptor is correlated with bad prognosis and MYCN amplification. Here we discuss the role of MYCN in neuroblastoma with a special focus on the contribution of elevated MYCN signaling for an aggressive and undifferentiated phenotype as well as the potential of using MYCN as a therapeutic target.

摘要

儿童神经母细胞瘤表现出异质性的临床行为,从具有自发分化和消退能力的低风险肿瘤到导致婴儿癌症相关死亡人数最多的高风险肿瘤。MYCN 癌基因扩增是少数不良预后的预测标志物之一。该基因编码 MYCN 转录调节剂,主要在发育中的周围神经嵴中表达。MYCN 对于增殖、迁移和干细胞稳态至关重要,而水平降低则与终末神经元分化有关。有趣的是,没有 MYCN 扩增的高危肿瘤经常显示出 c-MYC 表达增加和/或 MYC 信号通路的激活。另一方面,MYCN 的下调导致增殖和分化减少,强调了 MYC 信号在神经母细胞瘤生物学中的重要性。此外,神经营养因子受体 TrkA 的表达与良好的预后、分化和自发消退能力相关,而相关的 TrkB 受体的表达与不良预后和 MYCN 扩增相关。在这里,我们讨论了 MYCN 在神经母细胞瘤中的作用,特别关注升高的 MYCN 信号对侵袭性和未分化表型的贡献,以及将 MYCN 用作治疗靶点的潜力。

相似文献

1
The MYCN oncogene and differentiation in neuroblastoma.MYCN 癌基因与神经母细胞瘤分化。
Semin Cancer Biol. 2011 Oct;21(4):256-66. doi: 10.1016/j.semcancer.2011.08.001. Epub 2011 Aug 9.
2
Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells.在 MYCN 敲低介导的分化过程中上调的 mir-21 的抑制作用并不能阻止神经母细胞瘤细胞的分化。
Differentiation. 2011 Jan;81(1):25-34. doi: 10.1016/j.diff.2010.09.184. Epub 2010 Oct 25.
3
Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.MYCN/c-MYC 的转录活性差异与神经母细胞瘤的自发消退或恶性进展相关。
Genome Biol. 2008 Oct 13;9(10):R150. doi: 10.1186/gb-2008-9-10-r150.
4
Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis.神经母细胞瘤中微小RNA表达的差异模式与预后、分化及凋亡相关。
Cancer Res. 2007 Feb 1;67(3):976-83. doi: 10.1158/0008-5472.CAN-06-3667.
5
Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study.MYC和/或MYCN蛋白的过表达定义了高度侵袭性的MYC驱动的神经母细胞瘤:一项儿童肿瘤学组的研究。
Br J Cancer. 2015 Jun 30;113(1):57-63. doi: 10.1038/bjc.2015.188. Epub 2015 Jun 2.
6
MYCN silencing induces differentiation and apoptosis in human neuroblastoma cells.MYCN基因沉默可诱导人神经母细胞瘤细胞分化和凋亡。
Biochem Biophys Res Commun. 2006 Dec 8;351(1):192-7. doi: 10.1016/j.bbrc.2006.10.020. Epub 2006 Oct 12.
7
ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.ID2的表达与人类神经母细胞瘤中的MYCN扩增或表达无关。
Cancer Res. 2003 Apr 1;63(7):1631-5.
8
Neuroblastoma and MYCN.神经母细胞瘤与 MYCN
Cold Spring Harb Perspect Med. 2013 Oct 1;3(10):a014415. doi: 10.1101/cshperspect.a014415.
9
Conditional expression of retrovirally delivered anti-MYCN shRNA as an in vitro model system to study neuronal differentiation in MYCN-amplified neuroblastoma.逆转录病毒介导的抗MYCN短发夹RNA的条件性表达作为一种体外模型系统,用于研究MYCN扩增的神经母细胞瘤中的神经元分化。
BMC Dev Biol. 2011 Jan 3;11:1. doi: 10.1186/1471-213X-11-1.
10
TWIST1 is a direct transcriptional target of MYCN and MYC in neuroblastoma.TWIST1是神经母细胞瘤中MYCN和MYC的直接转录靶点。
Cancer Lett. 2015 Feb 1;357(1):412-418. doi: 10.1016/j.canlet.2014.11.056. Epub 2014 Dec 1.

引用本文的文献

1
Regulatory roles of insulin growth factor binding protein family in neuroblastoma cell proliferation and differentiation: Potential prognostic biomarkers and therapeutic targets for neuroblastoma.胰岛素生长因子结合蛋白家族在神经母细胞瘤细胞增殖和分化中的调控作用:神经母细胞瘤潜在的预后生物标志物和治疗靶点
Pediatr Discov. 2024 Jun 8;2(3):e68. doi: 10.1002/pdi3.68. eCollection 2024 Sep.
2
Single-Cell Atlas Reveals Tumorigenic Profiles and Immune Dynamics of Adrenal Incidentalomas.单细胞图谱揭示肾上腺偶发瘤的致瘤特征和免疫动态
Adv Sci (Weinh). 2025 Jun;12(22):e2413493. doi: 10.1002/advs.202413493. Epub 2025 Apr 7.
3
Peripheral neuroblastic tumors behaving badly: an update on high-risk morphologic and molecular groupings.
行为不良的外周神经母细胞瘤:高危形态学和分子分组的最新进展
Virchows Arch. 2025 May;486(5):895-903. doi: 10.1007/s00428-025-04083-9. Epub 2025 Mar 29.
4
Emerging Trends in Neuroblastoma Diagnosis, Therapeutics, and Research.神经母细胞瘤诊断、治疗与研究的新趋势
Mol Neurobiol. 2025 May;62(5):6423-6466. doi: 10.1007/s12035-024-04680-w. Epub 2025 Jan 13.
5
Regulation and Function of CCL2 and N-Myc in Retinoic Acid-treated Neuroblastoma Cells.视黄酸处理的神经母细胞瘤细胞中CCL2和N-Myc的调控与功能
Cancer Genomics Proteomics. 2025 Jan-Feb;22(1):90-102. doi: 10.21873/cgp.20490.
6
Prognostic model for hepatocellular carcinoma based on necroptosis-related genes and analysis of drug treatment responses.基于坏死性凋亡相关基因的肝细胞癌预后模型及药物治疗反应分析
Heliyon. 2024 Aug 22;10(17):e36561. doi: 10.1016/j.heliyon.2024.e36561. eCollection 2024 Sep 15.
7
The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis.转录共抑制因子 Runx1t1 对于 MYCN 驱动的神经母细胞瘤肿瘤发生是必需的。
Nat Commun. 2024 Jul 11;15(1):5585. doi: 10.1038/s41467-024-49871-0.
8
DFMO inhibition of neuroblastoma tumorigenesis.DFMO 抑制神经母细胞瘤肿瘤生成。
Cancer Med. 2024 May;13(9):e7207. doi: 10.1002/cam4.7207.
9
Identification of CDKN3 as a Key Gene that Regulates Neuroblastoma Cell Differentiation.鉴定CDKN3作为调节神经母细胞瘤细胞分化的关键基因。
J Cancer. 2024 Jan 1;15(5):1153-1168. doi: 10.7150/jca.89660. eCollection 2024.
10
Molecular Determinants of Neurocognitive Deficits in Glioma: Based on 2021 WHO Classification.胶质瘤神经认知缺陷的分子决定因素:基于2021年世界卫生组织分类
J Mol Neurosci. 2024 Feb 5;74(1):17. doi: 10.1007/s12031-023-02173-4.